Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$92.95 - $130.61 $609,101 - $855,887
-6,553 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$68.08 - $95.68 $615,170 - $864,564
-9,036 Reduced 57.96%
6,553 $610,000
Q1 2020

May 13, 2020

SELL
$61.71 - $101.95 $61,710 - $101,950
-1,000 Reduced 6.03%
15,589 $1.14 Million
Q4 2019

Feb 12, 2020

SELL
$70.08 - $84.64 $25,579 - $30,893
-365 Reduced 2.15%
16,589 $1.39 Million
Q3 2019

Oct 16, 2019

BUY
$62.38 - $85.89 $454,313 - $625,536
7,283 Added 75.31%
16,954 $1.43 Million
Q2 2019

Jul 17, 2019

SELL
$53.64 - $65.42 $6,651 - $8,112
-124 Reduced 1.27%
9,671 $633,000
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $251,591 - $359,605
5,095 Added 108.4%
9,795 $578,000
Q4 2018

Jan 15, 2019

BUY
$46.97 - $63.98 $220,759 - $300,706
4,700 New
4,700 $249,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.